66 related articles for article (PubMed ID: 22025370)
1. Data sources on drug safety evaluation: a review of recent published meta-analyses.
Alves C; Batel-Marques F; Macedo AF
Pharmacoepidemiol Drug Saf; 2012 Jan; 21(1):21-33. PubMed ID: 22025370
[TBL] [Abstract][Full Text] [Related]
2. Reporting of gender-related information in clinical trials of drug therapy for myocardial infarction.
Rochon PA; Clark JP; Binns MA; Patel V; Gurwitz JH
CMAJ; 1998 Aug; 159(4):321-7. PubMed ID: 9732709
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
Manchikanti L; Datta S; Smith HS; Hirsch JA
Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
[TBL] [Abstract][Full Text] [Related]
4. Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses.
Hart B; Lundh A; Bero L
BMJ; 2012 Jan; 344():d7202. PubMed ID: 22214754
[TBL] [Abstract][Full Text] [Related]
5. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
Hammad TA; Pinheiro SP; Neyarapally GA
Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
[TBL] [Abstract][Full Text] [Related]
6. Pitfalls in meta-analyses on adverse events reported from clinical trials.
Huang HY; Andrews E; Jones J; Skovron ML; Tilson H
Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1014-20. PubMed ID: 21858897
[TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A; Bellini P; Terracini B;
Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
[TBL] [Abstract][Full Text] [Related]
8. Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
LeLorier J; Grégoire G; Benhaddad A; Lapierre J; Derderian F
N Engl J Med; 1997 Aug; 337(8):536-42. PubMed ID: 9262498
[TBL] [Abstract][Full Text] [Related]
9. A new and rapid scoring system to assess the scientific evidence from clinical trials.
Silber S
J Interv Cardiol; 2006 Dec; 19(6):485-92. PubMed ID: 17107362
[TBL] [Abstract][Full Text] [Related]
10. Systematic reviews of medical evidence: the use of meta-analysis in obstetrics and gynecology.
Peipert JF; Bracken MB
Obstet Gynecol; 1997 Apr; 89(4):628-33. PubMed ID: 9083325
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].
Ibáñez Sendín MD
Allergol Immunopathol (Madr); 2000; 28(3):82-9. PubMed ID: 10867375
[TBL] [Abstract][Full Text] [Related]
12. Errors in the conduct of systematic reviews of pharmacological interventions for irritable bowel syndrome.
Ford AC; Guyatt GH; Talley NJ; Moayyedi P
Am J Gastroenterol; 2010 Feb; 105(2):280-8. PubMed ID: 19920807
[TBL] [Abstract][Full Text] [Related]
13. [Appraisal of meta-analysis manuscripts on eye diseases published in Chinese journals with QUOROM statement and MOOSE guidelines].
Zhu MM; Zou HD
Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):732-7. PubMed ID: 22169614
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring in pharmacovigilance and pharmacotherapy safety.
Haen E
Pharmacopsychiatry; 2011 Sep; 44(6):254-8. PubMed ID: 21959787
[TBL] [Abstract][Full Text] [Related]
15. Comparisons between ITT and treatment emergent adverse event analyses.
Quan H; Sun Q; Zhang J; Shih WJ
Stat Med; 2008 Nov; 27(26):5356-76. PubMed ID: 18618431
[TBL] [Abstract][Full Text] [Related]
16. An appraisal of meta-analysis guidelines: how do they relate to safety outcomes?
Bennetts M; Whalen E; Ahadieh S; Cappelleri JC
Res Synth Methods; 2017 Mar; 8(1):64-78. PubMed ID: 27612447
[TBL] [Abstract][Full Text] [Related]
17. Reporting of heterogeneity of treatment effect in cohort studies: a review of the literature.
Dahan M; Scemama C; Porcher R; Biau DJ
BMC Med Res Methodol; 2018 Jan; 18(1):10. PubMed ID: 29329525
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of clinical trial safety data in a drug development program: answers to frequently asked questions.
Berlin JA; Crowe BJ; Whalen E; Xia HA; Koro CE; Kuebler J
Clin Trials; 2013 Feb; 10(1):20-31. PubMed ID: 23171499
[TBL] [Abstract][Full Text] [Related]
19. Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals.
Prada-Ramallal G; Roque F; Herdeiro MT; Takkouche B; Figueiras A
BMC Med Res Methodol; 2018 Sep; 18(1):97. PubMed ID: 30261846
[TBL] [Abstract][Full Text] [Related]
20. Ongoing progress in research on drug exposure and adverse events.
Knottnerus JA; Tugwell P
J Clin Epidemiol; 2012 Oct; 65(10):1029-30. PubMed ID: 22910535
[No Abstract] [Full Text] [Related]
[Next] [New Search]
